Efficacy and safety of daily treatments for drug-susceptible pulmonary tuberculosis: a systematic review and network meta-analysis.
Priscila ImazuJosiane Marlei Muller Fernandes Dos SantosFrancisco Beraldi-MagalhãesFernando Fernandez-LllimosFernanda Stumpf ToninRoberto PontaroloPublished in: The Journal of pharmacy and pharmacology (2022)
The WHO standard regimen remains an overall effective and safe alternative for DS-TB. For intensive phase treatments, drugs combinations with rifapentine and moxifloxacin seem to reduce treatment duration while maintaining efficacy.